NURS FPX 4030 Assessment 4: Need for Further Information
Given more details about Caitlynn’s tests for lung function and specific CFTR gene
changes, her medical team might more accurately customize her treatment strategy.
Understanding the details of her cystic fibrosis diagnosis may help predict the way it will
progress and identify the most effective therapies for the child (Patel et al., 2022). The
outcomes of the pulmonary function exams would provide a reference point for comparing
the advancement or decline in her breathing ability in years to come. Using that data, a
respiratory professional may determine the ideal amount and length for Caitlynn’s airwayclearing treatments.
If the staff had additional information regarding her parents’ work schedules, accessibility to conveyance, and level of technical convenience, they would be more qualified to choose the mediums and timeframe for virtual care and ongoing education
(Shah et al., 2022). A more targeted, customized approach for Caitlynn would be made
possible by early medical facilities’ interpersonal and administrative data gathering.
Evidence-Based Practice Model
The Stetler model provides the structure for integrating research findings and data into
the clinical setting, which strongly focuses on thinking critically and using private
organization data. Caitlynn’s treatment plan was developed using the Stetler approach, which
includes five stages that follow:
To prepare Caitlynn for evidence-based therapy, her medical group first concentrated
on curing her pneumonia, improving her respiratory health, and preventing further
complications. Next, using resources, including medical recommendations and scientific
journals, the team searched for and evaluated external studies on cystic fibrosis treatment
therapy (Somayaji et al., 2020). The relevant studies on medications, vitamin supplements for
cleaning the respiratory tract, and other subjects were gathered.
The group then considered Caitlynn’s unique circumstances, including her remote residence, family dynamics, and the available resources nearby, as they examined the information in question. They concluded that Caitlynn might plausibly have the outside evidence used in her argument if her social
circumstances were slightly altered. The research data was interpreted into a whole therapy
regimen for Caitlynn during the fourth phase, which included further investigation and
synchronized education strategies, medications, treatments, and monitoring protocols
(Kavalieratos et al., 2020).
Lastly, the entire group will evaluate the outcomes by monitoring Caitlynn’s
development in dietary habits, her way of life, and lung function. Her response will guide any
alterations to the plan. The Stetler approach simplifies identifying the best evidence, deciding
how to apply it to Caitlynn, and turning it into a comprehensive, customized therapy program
(Schallmoser et al., 2023).
Evaluation of Positive Results
Her medical team may track Caitlynn’s wellness via regular assessments between clinic appointments and online medical care sessions. Monitoring emergency room trips and hospital stays due to bowel blockages or respiratory infections, tracking variations in the size and weight of her ranges, and keeping an eye on her lung function via pulmonary function testing are all measurable outcomes.
Surveys and conversations can also be employed during subsequent appointments to assess patient feedback, including compliance with medications, parental trust in providing treatment, Caitlynn’s positive outlook on existence, and handling her CF complaints. By integrating objective clinical data with emotional quality-of-life input from Caitlynn and her companions, the medical professionals will be able to evaluate the positive impacts of the evidence-based medication regimen on Caitlynn’s achievements (Quittner et al., 2020).
Evidence Relation to Decision-Making
The therapeutic recommendations of the Cystic Fibrosis Foundation provided a
precious body of study data for Caitlynn’s therapy. Their comprehensive suggestions as the
leading authority on treating cystic fibrosis outlined the minimum needed to improve
nutrition, prevent complications, manage respiratory problems, and organize
multidisciplinary care.
Specifically, they provided guidance on best practices for managing
Caitlynn’s disease, including clearing her breathing passages using inhaled medications like
dornase alfa, supplementing fat-soluble vitamins, and determining the appropriate dosage of
enzymes from the pancreas (Nowak et al., 2021). Their guidance for tracking the co